Author

Z. Meshkat

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:proteomics· 2 Approach:statistical model· 2 Research Focus:variant calling· 2 Organism:virus· 2 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Assay:metagenomics· 1 Organism:mouse· 1

Frequent Co-Authors

K. Rahimian· 2 shared M. Abavisani· 2 shared M. Mahmanzar· 2 shared R. Khayami· 2 shared A. Yousefi Avarvand· 1 shared E. Aryan· 1 shared F. Khademi· 1 shared M. Kodori· 1 shared

Activity by Year

2021-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

K. Rahimian

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Investigating the mutations in the SARS-CoV-2 proteins among European countries

M. Abavisani, K. Rahimian, R. Khayami, M. Kodori, M. M. Sisakht, M. Mahmanzar, Z. Meshkat

The paper analyzes mutations in SARS-CoV-2 structural proteins across European countries, identifying common mutations and their distribution in amino-acid sequences.

bioRxiv · Jun 23, 2022 · PreprintMicrobiology

Mutational insights among the structural proteins of SARS-CoV-2: frequencies and evolutionary trends in American countries

M. Abavisani, K. Rahimian, R. Khayami, M. Mollapour Sisakht, M. Mahmanzar, Z. Meshkat

This study analyzes mutation frequencies and evolutionary trends in SARS-CoV-2 structural proteins across American countries and globally to inform drug and vaccine strategies.

bioRxiv · Jun 22, 2022 · PreprintMicrobiology

Enhancement of the immunogenicity of a Mycobacterium tuberculosis fusion protein using ISCOMATRIX and PLUSCOM nano-adjuvants after nasal administration in mice

A. Yousefi Avarvand, Z. Meshkat, F. Khademi, E. Aryan, M. Sankian, M. Tafaghodi

This study evaluates the immunogenicity of a Mycobacterium tuberculosis fusion protein with adjuvants via nasal vaccination in mice, showing enhanced IFN-γ and sIgA responses.

bioRxiv · Aug 27, 2021 · PreprintMicrobiology